Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
11/2008
11/27/2008WO2007149288A3 C1-inhibitor prevents non-specific plasminogen activation by a prourokinase mutant without impeding fibrin-specific fibrinolysis
11/27/2008WO2007143183A3 Methods for developing and assessing therapeutic agents
11/27/2008WO2007136874A3 Genomic library construction
11/27/2008WO2007118073A3 Obesity and body fat distribution
11/27/2008WO2007117642A3 Neisseria gonorrhoeae specific oligonucleotide sequences
11/27/2008WO2007100908A3 Chimeric adenoviral vectors
11/27/2008WO2007100875A3 Nac-i as a prognostic marker and a target for therapeutic target in human cancer
11/27/2008WO2007098326A3 Method for screening hiv drug sensitivity
11/27/2008WO2007097857A3 Multidimensional organization of heteromolecules by robust dna motifs
11/27/2008WO2007095387A3 Compositions and methods for inhibiting gene silencing by rna interference
11/27/2008WO2007095055A3 Methods and compositions for detecting viral nucleic acid in a cell
11/27/2008WO2006091470A3 Improved halohydrin dehalogenases and related polynucleotides
11/27/2008WO2006044612A3 Development of sensitive fret sensors and methods of using the same
11/27/2008WO2005030981A3 Homogeneous populations of molecules
11/27/2008US20080295202 Soybean promoters SC194 and flower-preferred expression thereof in transgenic plants
11/27/2008US20080295192 Self-induced deletion of dna
11/27/2008US20080295190 comprising a Cricetulus griseus ( FAIM, FADD, PDCD6 and Requiem) sequence capable of mediating apoptosis of cells
11/27/2008US20080293929 Synthesis of sulfurized oligonucleotides
11/27/2008US20080293928 Cytochrom P450 oxygenases
11/27/2008US20080293920 Arginine Analogs, and Methods for Their Synthesis and Use
11/27/2008US20080293919 Fibrous Protein Fusions and Use Thereof in the Formation of Advanced Organic/Inorganic Composite Materials
11/27/2008US20080293662 RNAi MODULATION OF THE BCR-ABL FUSION GENE AND USES THEREOF
11/27/2008US20080293660 Chemically-defined non-polymeric valency platform molecules and conjugates thereof
11/27/2008US20080293659 FC gamma RIIA-specific nucleic acid interference
11/27/2008US20080293657 Modulation of the expression of stat-1-dependent genes
11/27/2008US20080293656 Processing nucleic acid
11/27/2008US20080293655 Novel tandem siRNAS
11/27/2008US20080293629 Albumin Fusion Proteins
11/27/2008US20080293610 Use and production of storage-stable neutral metalloprotease
11/27/2008US20080293607 Alkaliphilic Bacillus Species alpha-Amylase Variants, Compositions Comprising alpha-Amylase Variants, And Methods of Use
11/27/2008US20080293595 siRNA targeting protein tyrosine phosphatase-1B (PTP1B)
11/27/2008US20080293593 siRNA targeting casitas B cell lymphoma-B (CBL-B)
11/27/2008US20080293586 Fluorescent probes for dna detection by hybridization with improved sensitivity and low background
11/27/2008US20080293580 Methods for Detecting and Measuring Specific Nucleic Acid Sequences
11/27/2008US20080293136 Nucleic acid compounds for inhibiting akt gene expression and uses thereof
11/27/2008US20080293124 Multimeric Oxidoreductases
11/27/2008US20080293119 B12 dependent dehydratases with improved reaction kinetics
11/27/2008US20080293118 Magnetic fine particles having lower critical solution temperature
11/27/2008US20080293115 Plant wall degradative compounds and systems
11/27/2008US20080293087 Sulfonylurea receptor short forms from mitochondria and uses thereof
11/27/2008US20080293070 Markers for Memory T Cells and Uses Thereof
11/27/2008US20080293067 Probe, probe set, probe carrier, and testing method
11/27/2008US20080293066 Probe, probe set, probe carrier, and testing method
11/27/2008US20080293065 Probe, probe set, probe carrier, and testing method
11/27/2008US20080293064 Probe, probe set, probe carrier, and testing method
11/27/2008US20080293063 Probe, probe set, probe carrier, and testing method
11/27/2008US20080293062 Probe, probe set, probe carrier, and testing method
11/27/2008US20080293061 Probe, probe set, probe carrier, and testing method
11/27/2008US20080293053 shRNA Materials and Methods of Using Same for Inhibition of DKK-1
11/27/2008US20080293049 diagnosing HBV, HCV and HIV of a suspected patient; different primer sets and specific probes
11/27/2008US20080293039 VP7 gene of human rotavirus and composition for diagnosis of human rotavirus infection comprising primer or probe specific to thereof
11/27/2008US20080293037 Sequences Diagnostic For Shrimp Pathogens
11/27/2008US20080293035 Nucleic Acid Isolation
11/27/2008US20080292704 Methods and Compositions Involving Polymeric Immunoglobulin Fusion Proteins
11/27/2008US20080292654 Human Bocavirus and Methods of Diagnosis and Treatment
11/27/2008US20080292649 Composition for improving membrane composition and functioning of cells
11/27/2008US20080292648 Synthetic agonists of tlr9
11/27/2008US20080292634 Nontypable Haemophilus Infuenzae Virulence Factors
11/27/2008US20080292633 Compositions and methods for the therapy and diagnosis of lung cancer
11/27/2008US20080292632 Irta2 Antibodies and Methods of Use
11/27/2008US20080292628 Chimeric Protein
11/27/2008US20080292623 Mammalian cell membrane proteins; related reagents
11/27/2008US20080292619 Pharmaceutical Composition Containing Meltrin Antagonist
11/27/2008US20080292617 Antibody against a peptide derived from human mutant lamin a protein and uses thereof
11/27/2008CA2688536A1 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cancer
11/27/2008CA2685515A1 Synthesis of oligonucleotides
11/26/2008EP1995330A1 Modified oligonucleotides for mismatch discrimination
11/26/2008EP1995253A1 Method for detaching protecting group on nucleic acid
11/26/2008EP1995252A1 Method for removal of nucleic acid-protecting group
11/26/2008EP1994937A2 Prevention and treatment of amyloidogenic disease
11/26/2008EP1994183A2 A non-invasive method for diagnosing fetal cells and cancer cells
11/26/2008EP1994182A2 Degenerate nucleobase analogs
11/26/2008EP1994180A2 High throughput genome sequencing on dna arrays
11/26/2008EP1994176A2 Methods and agents for modulating an immune response
11/26/2008EP1994043A2 Phosphatase inhibitor protein-1 as a regulator of cardiac function
11/26/2008EP1993597A2 Human telomerase reverse transcriptase peptides
11/26/2008EP1922420A4 METHOD AND SUBSTANCES FOR ISOLATING miRNAs
11/26/2008EP1543142B1 Production method for iturin a and its homologues
11/26/2008EP1527172B1 Method for nucleic acid extraction and nucleic acid purification
11/26/2008EP1309730B1 New hydrazide building blocks and hydrazide modified biomolecules
11/26/2008EP1185544B1 Method for deblocking of labeled oligonucleotides
11/26/2008CN101313066A Modulation of glucocorticoid receptor expression
11/26/2008CN101312985A Polynucleotide containing a phosphate mimetic
11/26/2008CN101311185A Gene directed molecular evolution system in vitro based on half-rational evolutionary design
11/26/2008CN100436578C Modulation of the transcription of pro-inflammatory gene products
11/26/2008CN100436472C Pyrroles substituted by oligonucleotides
11/26/2008CN100436471C Polynucleotide for identifying polypeptide OT3 and coding OT3 of tumor cell and uses thereof
11/26/2008CN100436470C Polynucleotide for identifying polypeptide OT10 and coding OT10 of tumor cell and uses thereof
11/26/2008CN100436469C Selectively coating metal to nucleic acid by nano metal particles generated in-situ
11/25/2008US7456274 Inhibition of metallo-β-lactamase
11/25/2008US7456273 isolated transcriptional regulatory element selected from any of SEQ ID NOS: 40; recombinant nucleic acid molecule; integrating oligonucleotide into a eukaryotic cell genome so oligonucleotide is operatively linked to an expressible polynucleotide; detecting change in expression; kit; vector
11/25/2008US7456272 Neurotoxins with enhanced target specificity
11/25/2008US7456271 Glutamate 2,3-aminomutases and methods of use thereof
11/25/2008US7456269 Alzheimer's disease secretase, APP substrates thereof, and uses thereof
11/25/2008US7456268 Purified morpholino modified oligonucleotide; anticarcinogenic and antitumor agents; medical diagnosis; wild-type p53-induced phosphatase1 (Wip1); gene expression inhibition; drug screening
11/25/2008US7456266 Detectable labeled nucleoside analogs and methods of use thereof
11/25/2008US7456264 Human monoclonal antibodies against Bacillus anthracis protective antigen
11/25/2008US7456261 PRO9830 antibodies
11/25/2008US7456260 Humanized antibody
11/25/2008US7456154 Antisense oligonucleotide against human acetylcholinesterase (AChE) and uses thereof
1 ... 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 ... 899